Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13209034 | 0.80 | IDO1 (0.32) | — | |
| SCHEMBL1396689 | 0.80 | IDO1 (0.32) | — | |
| SCHEMBL31141331 | 0.80 | IDO1 (0.32) | — | |
| SCHEMBL28901121 | 0.79 | — | — | |
| SCHEMBL13907263 | 0.79 | — | — | |
| SCHEMBL6239918 | 0.78 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL18356050 | 0.76 | SHBG (0.37) | SHBGTP53EPHX1CA12CA1 | |
| Propionic Acid SCHEMBL1044207 | 0.76 | — | — | |
| SCHEMBL5852406 | 0.75 | ALDH1A1 (0.33) | MAPTEPHX1CA12CA1CA2 | |
| SCHEMBL5852392 | 0.75 | EPHX1 (0.33) | EPHX1CA12CA1CA2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1492759-B1 | NOVEL ALICYCLIC ESTERS HAVING A MUSKY SMELL | SYMRISE GMBH & CO KG (DE) | 2010-08-04 | — | — | EP | disclosed |
| US-7064102-B2 | Alicyclic esters having a musky smell | SYMRISE GMBH & CO, KG (DE) | 2006-06-20 | — | — | US | disclosed |
| US-20050182273-A1 | Novel alicyclic esters having a musky smell | SYMRISE AG (DE) | 2005-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182273-A1 | Novel alicyclic esters having a musky smell | TAS2R16, TAS2R43, TAS2R45 | SHBG 3069/4885TP53 2893/4885KDM4E 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.